Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Proteomics Research of Breast Cancer Markers in Interstitial Fluid and Serum

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by University of Pittsburgh
Sponsor:
Collaborator:
David Scaife Foundation
Information provided by (Responsible Party):
Min Sun, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01042548
First received: January 4, 2010
Last updated: March 15, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)